Details
Category: Volume 07 Issue 07 July 2019
Hits: 1035

Title: A Study of Clinical Presentation and Risk Factors of Carcinoma Rectum

Authors: Dr Prashanth Thalluri MS, Dr T Dheeraj, Dr K Naveen; MS, Dr V Tata Rao; MS

 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.59

Abstract

Aims and Objectives

  1. To study age distribution of carcinoma rectum.
  2. To study sex distribution of carcinoma rectum.
  3. To study varied clinical presentation of carcinoma rectum.
  4. To study the risks associated with various lifestyle factors.

Etiology of Carcinoma Rectum

The development of colorectal malignancy involves interplay between genetic and environmental influences. Colorectal cancers that develop in individuals without hereditary links are referred to as “sporadic,” and account for 75% of all colorectal cancers. A potential genetic influence is identified in the remaining 25% of patients, including family history (15% to 20%); Lynch syndrome (5%); and FAP (<1%).

The aetiology is multifactorial and includes risk factors such as: increasing age, male sex and previous colorectal cancer. Lifestyle factors may also contribute to a higher risk. Lack of physical activity, low fruit and vegetable intake, low fibre and a high fat diet, overweight and obesity, tobacco use and alcohol consumption have all been associated with a higher risk.1

Adenoma is the precursor to rectal carcinoma. Approximately 10% of adenomas progress to invasive carcinomas through a well-defined sequence of genetic change called the adenoma-carcinoma sequence. This process may take 10 to15 years.

Inflammatory Bowel Disease

Patients with inflammatory bowel disease (IBD) are at significantly increased risk for developing colorectal cancer; the risk is proportional to the extent and duration of disease. In ulcerative colitis patients, where the risk of cancer appears to begin after 8 to 10 years of disease and increases at a rate of about 0.5% to 1.0% per year. Currently it is believed that the cancer risk is equivalent in Crohn and ulcerative colitis patients who have disease of similar duration and extent. An increased risk is also seen in patients with an onset of Crohn’s disease before the age of 30 years.

Hereditary Rectal Cancer

About 20% of all rectal cancer cases might have a familial component. Most of the known familial syndromes are inherited in an autosomal-dominant pattern, resulting in a 50% risk for a child of an affected individual to bear the predisposition for the cancer form.

References

  1. Parkin DM. International variation. Oncogene 2004;23:6329-40
  2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics.CA Cancer J Clin 1999;49:33-64.
  3. Centre for diseasecolorectal cancer risk factors 2009.
  4. Heriot AG, Hicks RJ, Drummond EG, etal. Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Diseases of the colon and rectum.Apr 2004;47(4):451-458.
  5. Vogelstein B, fearon ER, HanniltonSR, genetic alterations during colorectal tumor no development Nengl J Medsep 1 1998,31(9) 525-532
  6. Surgery OCSSFC national guidelines for colorectal cancer 2008.
  7. Cunningham D, Atkin wlenz HJ et al colorectal cancer Lancetmarzo 2010:375 (97 19): 1030-1047.
  8. Japersonkw, Tuohy Tm, nekalson DW, brut RW, hereditary and familial colon cancer, gastroentroloxlgy june 610:130(6):2044-2058.
  9. Jemal A, Brag F centre mm et al global cancer statistics, CA cancer selin ,2011,61:69.
  10. Mohandas km, desi DC, epidemiology of digestive cancers in indiaV.large and small bowel .indian j gastro enterol 1999jul sep 18(3):118-121.
  11. Keighley MRB, Williams NS. Surgery of the anus, rectum and colon.Second edition ed. London: W.B.Saunders;1993.
  12. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM classification of malignanattumours. 7th Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell; 2010.
  13. Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol 1994;10:12-20.
  14. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ.Oct14 2006;333(7572):779
  15. Burton S, Brown G, Daniels I, etal.MRI identified prognostic features of tumours in distal sigmoid,rectosigmoid,and upper rectum:treatment with radiography and chemotherapy.Int J Radiat Oncol Biol Phys. Jun 1 2006;65(2):445-451
  16. Mac Dermid E, Hooton G, MacDonald M, etal. Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis.Mar 2009;11(3):291-295.
  17. Deo SV, Shukla NK, Srinivas G, Mohanti BK, Raina V, Sharma A, Rath GK. Colorectal cancers-experience at a regional cancer centre in India.Trop Gastroenterol. 2001Apr-Jun;22(2):83-86.
  18. Eltinay OF, Guraya SY. Colorectal carcinoma: Clinico pathological pattern and outcome on surgical management. Saudi J Gastroenterol 2006;12:83-86.
  19. Aljebreen AM. Clinico pathological patterns of colorectal cancer in Saudi Arabia: Younger with an advanced stage presentation.Saudi J Gastroenterol 2007;13:84-87.
  20. Rasool S, Bari S, Rashid A, Wani R,Wani G. Peer:Outcome of patients with acute intestinal obstruction due to coloretalcarcinoma. Int J Surg 2009; 20: DOI:10.5580/C35.
  21. Sudarshan V, Hussain N,Gahine R, Mourya J.Colorectal cancer in young adults in a teritiary care hospital in Chhattisgarh, Raipur. Indian J Cancer 2013;50:337-340.
  22. Ferlay J, Shin HR, Bray F, etal GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.10.Lyon, France: International Agency for Research on Cancer;2010.
  23. Parkin D, Wheelan SI,Ferlay J,etal. Cancer Incidence in Five Continents;Vol.1 to 7.Lyon:IARC 2005.
  24. Centres for disease control and prevention. http://www.cdc.gov/cancer/colorectal/statistics/race.htm.2011.
  25. Goldacre MJ, Wotton CJ, Yeates D,et al. Cancer in patients with ulcerativecolitis, Crohn’s disease and coeliac disease:record linkage study. Eur J GastroenterolHepatol 2 008:20:297-304.
  26. Lynch H,de la ChapelleA.Hereditary Colorectal cancer. NEngl J Med 2003;348:919-932.
  27. Weitz J, Koch M, Debus J,etal. Colorectal cancer. Lancet 2005;365:153-165.
  28. McSherry C, Cornell G, Glenn F. Carcinoma of the colon and rectum.Ann Surg, 1969. 169:p502-509.
  29. Bretagnol F, Rullier E,George B,et al. Local therapy for colorectal cancer. Still Contraversial? Dis Colon Rectum, 2007.50:p523-533.
  30. Minardi AJ Jr., Sittig KM, Zibari GB, McDonald JC. Colorectalcancr in the young patient.AmSurg 1998;64:849-853

Corresponding Author

Dr Prashanth Thalluri MS

3rd Year Post Graduate, Department of General Surgery, NRI Academy of Sciences, Chinakakani